Lutein Supplementation in Healthy Children
Primary Purpose
Eye Fatigue, Diet, Healthy, Cognitive Change
Status
Recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
lutein
placebo
Sponsored by
About this trial
This is an interventional treatment trial for Eye Fatigue focused on measuring lutein, carotenoids, blue light, screen time, digital stress
Eligibility Criteria
Inclusion Criteria:
- Age of 8 to 16 years
- guardian-reported general good health
- guardian-reported 4 hours or more of digital screen time daily
Exclusion Criteria:
- Currently using a supplement containing lutein or zeaxanthin
Sites / Locations
- Kemin IndustriesRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Lutein
Placebo
Arm Description
5 mg lutein gummy taken daily for 180 days
0 mg lutein gummy taken daily for 180 days
Outcomes
Primary Outcome Measures
Macular Pigment Optical Density - heterochromatic flicker photometry
Level of macular carotenoids deposited in the eye measured using the psychophysical technique of heterochromatic flicker photometry (QuantifEye MPS-II Device). Minimum score of 0, no maximum. Average values range from 0.0 to 1.0. Higher numbers represent greater macular pigment.
Macular Pigment Optical Density - haidinger's brushes
Level of macular carotenoids deposited in the eye measured using haidinger's brushes (Azul Optics MP-Eye Device). Minimum score of 0, maximum score of 10. Higher values represent greater macular pigment.
Secondary Outcome Measures
Digital Eye strain change from baseline
Visual Fatigue Scale total score. Minimum score of 6, Maximum score of 24. Higher scores indicate higher levels of digital eye strain.
Benedetto, S., Drai-Zerbib, V., Pedrotti, M., Tissier, G., & Baccino, T. (2013). E-readers and visual fatigue. PLoS One, 8(12)
Sleep score change from baseline
Total score on the Cleveland Adolescent Sleepiness Questionnaire. Minimum score of 16, Maximum score of 80. Higher scores indicate greater sleepiness.
Spilsbury, J. C., et al. (2007). "The Cleveland adolescent sleepiness questionnaire: a new measure to assess excessive daytime sleepiness in adolescents." J Clin Sleep Med 3(6): 603-612.
Verbal Fluency
Letter and semantic fluency using letter and animal naming. Total number of words names in a 60 second time frame. Higher score indicates greater verbal fluency
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT05314647
Brief Title
Lutein Supplementation in Healthy Children
Official Title
Effects of Lutein Supplementation on Cognition and Vision in Healthy Children With Screen Time Exposure: A Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
June 2023
Overall Recruitment Status
Recruiting
Study Start Date
July 2023 (Anticipated)
Primary Completion Date
November 2023 (Anticipated)
Study Completion Date
February 2024 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Northcentral University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
This is a single site, randomized, double-blind placebo controlled parallel arm study assessing the effects of 6 months lutein supplementation on cognitive and visual outcomes in healthy children exposed to excessive digital screen time.
Detailed Description
Studies in humans and primates have also shown that appropriate daily intake of lutein provides protection to the eyes from blue light from screen time devices such as computers, televisions and phones. It has been well-documented that children are spending far over the recommended two hours screen time per day and excessive exposure to the high energy blue light associated with digital devices has been shown to cause both short-term and long-term visual damage as well as disruption to the sleep cycle. With a globally aging population, if this deficit is not addressed adequately early on in life then there will be substantial public health consequences. A recent study predicted that if individuals were to consume the recommended levels of lutein and zeaxanthin daily, there would be a seven percent reduced risk for age related eye disease and a potential savings of over five billion US dollars annually.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Eye Fatigue, Diet, Healthy, Cognitive Change
Keywords
lutein, carotenoids, blue light, screen time, digital stress
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
randomized, double-blind, placebo controlled
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Each participant will be assigned to a group based on a permuted block randomization stratified by participant self-reported sex. Participants may identify male, female or other. If other is selected, assignment as male or female for randomization purposes will be determined by a coin flip. Randomized block lists with a size of 4 will be prepared using a computer generated random number sequence, http://www.jerrydallal.com/random/assigndoc.htm#num (J. Kim & Shin, 2014). Based on group placement, participants will be provided with Bottle A or Bottle B of gummies to last for the next 90 days.
Allocation
Randomized
Enrollment
70 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
Lutein
Arm Type
Experimental
Arm Description
5 mg lutein gummy taken daily for 180 days
Arm Title
Placebo
Arm Type
Placebo Comparator
Arm Description
0 mg lutein gummy taken daily for 180 days
Intervention Type
Dietary Supplement
Intervention Name(s)
lutein
Other Intervention Name(s)
FloraGLO Lutein
Intervention Description
daily dose of 5 mg lutein
Intervention Type
Dietary Supplement
Intervention Name(s)
placebo
Intervention Description
daily dose of 0 mg lutein
Primary Outcome Measure Information:
Title
Macular Pigment Optical Density - heterochromatic flicker photometry
Description
Level of macular carotenoids deposited in the eye measured using the psychophysical technique of heterochromatic flicker photometry (QuantifEye MPS-II Device). Minimum score of 0, no maximum. Average values range from 0.0 to 1.0. Higher numbers represent greater macular pigment.
Time Frame
6 months
Title
Macular Pigment Optical Density - haidinger's brushes
Description
Level of macular carotenoids deposited in the eye measured using haidinger's brushes (Azul Optics MP-Eye Device). Minimum score of 0, maximum score of 10. Higher values represent greater macular pigment.
Time Frame
6 months
Secondary Outcome Measure Information:
Title
Digital Eye strain change from baseline
Description
Visual Fatigue Scale total score. Minimum score of 6, Maximum score of 24. Higher scores indicate higher levels of digital eye strain.
Benedetto, S., Drai-Zerbib, V., Pedrotti, M., Tissier, G., & Baccino, T. (2013). E-readers and visual fatigue. PLoS One, 8(12)
Time Frame
6 months
Title
Sleep score change from baseline
Description
Total score on the Cleveland Adolescent Sleepiness Questionnaire. Minimum score of 16, Maximum score of 80. Higher scores indicate greater sleepiness.
Spilsbury, J. C., et al. (2007). "The Cleveland adolescent sleepiness questionnaire: a new measure to assess excessive daytime sleepiness in adolescents." J Clin Sleep Med 3(6): 603-612.
Time Frame
6 months
Title
Verbal Fluency
Description
Letter and semantic fluency using letter and animal naming. Total number of words names in a 60 second time frame. Higher score indicates greater verbal fluency
Time Frame
6 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
8 Years
Maximum Age & Unit of Time
16 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Age of 8 to 16 years
guardian-reported general good health
guardian-reported 4 hours or more of digital screen time daily
Exclusion Criteria:
Currently using a supplement containing lutein or zeaxanthin
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Brenda Fonseca, MA
Phone
515-421-0680
Email
brenda@brendafonseca.com
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Patrick McNamara, PhD
Organizational Affiliation
Northcentral University
Official's Role
Study Chair
Facility Information:
Facility Name
Kemin Industries
City
Des Moines
State/Province
Iowa
ZIP/Postal Code
50307
Country
United States
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Brenda Fonseca, MA
Phone
515-421-0680
First Name & Middle Initial & Last Name & Degree
Brenda Fonseca, MA
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Lutein Supplementation in Healthy Children
We'll reach out to this number within 24 hrs